These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 10732776

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A, Hahne JC, Haddouti el-M, Florin A, Wellmann A, Wernert N.
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a stromal cell model of the human benign and malignant prostate from explant culture.
    Planz B, Kirley SD, Wang Q, Tabatabaei S, Aretz HT, McDougal WS.
    J Urol; 1999 Apr; 161(4):1329-36. PubMed ID: 10081903
    [Abstract] [Full Text] [Related]

  • 6. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
    Nishimura K, Takada S, Miura H, Tsujimura A, Kitamura M, Nonomura N, Matsumiya K, Okuyama A.
    Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
    [Abstract] [Full Text] [Related]

  • 7. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP.
    King KJ, Nicholson HD, Assinder SJ.
    Prostate; 2006 Jan 01; 66(1):105-14. PubMed ID: 16114065
    [Abstract] [Full Text] [Related]

  • 8. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM.
    J Cell Physiol; 2002 May 01; 191(2):208-16. PubMed ID: 12064464
    [Abstract] [Full Text] [Related]

  • 9. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG, Gardner WA.
    Med Hypotheses; 2008 May 01; 70(2):387-408. PubMed ID: 17658698
    [Abstract] [Full Text] [Related]

  • 10. A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells.
    Kawada M, Yoshimoto Y, Minamiguchi K, Kumagai H, Someno T, Masuda T, Ishizuka M, Ikeda D.
    Anticancer Res; 2004 May 01; 24(3a):1561-8. PubMed ID: 15274323
    [Abstract] [Full Text] [Related]

  • 11. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels.
    Hall JA, Maitland NJ, Stower M, Lang SH.
    Cancer Res; 2002 Jan 01; 62(1):58-62. PubMed ID: 11782359
    [Abstract] [Full Text] [Related]

  • 12. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, Usui T, Kamiya K.
    Biochem Biophys Res Commun; 2004 Jul 30; 320(3):656-63. PubMed ID: 15240098
    [Abstract] [Full Text] [Related]

  • 13. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.
    Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG, Horsfall DJ.
    Cancer Res; 2001 Feb 01; 61(3):926-30. PubMed ID: 11221884
    [Abstract] [Full Text] [Related]

  • 14. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
    Kuniyasu H, Chihara Y, Kondo H, Ohmori H, Ukai R.
    Oncol Rep; 2003 Feb 01; 10(6):1863-8. PubMed ID: 14534709
    [Abstract] [Full Text] [Related]

  • 15. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 01; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

  • 16. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J, Arnold JT, Isaacs JT.
    Cancer Res; 2001 Jul 01; 61(13):5038-44. PubMed ID: 11431338
    [Abstract] [Full Text] [Related]

  • 17. Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures.
    Lang SH, Sharrard RM, Stark M, Villette JM, Maitland NJ.
    Br J Cancer; 2001 Aug 17; 85(4):590-9. PubMed ID: 11506501
    [Abstract] [Full Text] [Related]

  • 18. Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma.
    Nunn SE, Peehl DM, Cohen P.
    J Cell Physiol; 1997 May 17; 171(2):196-204. PubMed ID: 9130467
    [Abstract] [Full Text] [Related]

  • 19. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.
    Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ, Maitland NJ.
    Prostate; 2002 Sep 01; 52(4):253-63. PubMed ID: 12210485
    [Abstract] [Full Text] [Related]

  • 20. Negative control of epithelial cell proliferation by prostatic stroma.
    Kooistra A, König JJ, Romijn JC, Schröder FH.
    Anticancer Res; 1991 Sep 01; 11(4):1495-500. PubMed ID: 1720936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.